These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

774 related articles for article (PubMed ID: 26073325)

  • 1. Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy.
    Sun C; Sun HY; Xiao WH; Zhang C; Tian ZG
    Acta Pharmacol Sin; 2015 Oct; 36(10):1191-9. PubMed ID: 26073325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Putative Role of Natural Killer Cells in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma.
    Hassouna MM; Radwan EM; Abdelsameea E; Estaphan S; Abd Elrhman HE; Abdel-Samiee M; Naguib M
    Asian Pac J Cancer Prev; 2021 Aug; 22(8):2559-2567. PubMed ID: 34452571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma.
    Sun C; Sun H; Zhang C; Tian Z
    Cell Mol Immunol; 2015 May; 12(3):292-302. PubMed ID: 25308752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural Killer Cells and T Cells in Hepatocellular Carcinoma and Viral Hepatitis: Current Status and Perspectives for Future Immunotherapeutic Approaches.
    Kalathil SG; Thanavala Y
    Cells; 2021 May; 10(6):. PubMed ID: 34071188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanded and Activated Natural Killer Cells for Immunotherapy of Hepatocellular Carcinoma.
    Kamiya T; Chang YH; Campana D
    Cancer Immunol Res; 2016 Jul; 4(7):574-81. PubMed ID: 27197065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. hIL-15 gene-modified human natural killer cells (NKL-IL15) augments the anti-human hepatocellular carcinoma effect in vivo.
    Jiang W; Zhang C; Tian Z; Zhang J
    Immunobiology; 2014 Jul; 219(7):547-53. PubMed ID: 24721706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Energy metabolism and cell motility defect in NK-cells from patients with hepatocellular carcinoma.
    Zecca A; Barili V; Canetti D; Regina V; Olivani A; Carone C; Capizzuto V; Zerbato B; Trenti T; Dalla Valle R; Ferrari C; Cariani E; Missale G
    Cancer Immunol Immunother; 2020 Aug; 69(8):1589-1603. PubMed ID: 32307580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
    Marotta F; Vangieri B; Cecere A; Gattoni A
    Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diminished absolute counts of CD56dim and CD56bright natural killer cells in peripheral blood from Egyptian patients with hepatocellular carcinoma.
    Fathy A; Eldin MM; Metwally L; Eida M; Abdel-Rehim M
    Egypt J Immunol; 2009; 16(2):17-25. PubMed ID: 22059350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis virus infection affects DNA methylation in mice with humanized livers.
    Okamoto Y; Shinjo K; Shimizu Y; Sano T; Yamao K; Gao W; Fujii M; Osada H; Sekido Y; Murakami S; Tanaka Y; Joh T; Sato S; Takahashi S; Wakita T; Zhu J; Issa JP; Kondo Y
    Gastroenterology; 2014 Feb; 146(2):562-72. PubMed ID: 24184133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NK cells in hepatitis B virus infection: a potent target for immunotherapy.
    Shabani Z; Bagheri M; Zare-Bidaki M; Hassanshahi G; Arababadi MK; Mohammadi Nejad M; Kennedy D
    Arch Virol; 2014 Jul; 159(7):1555-65. PubMed ID: 24445811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural Killer Cell Dysfunction in Hepatocellular Carcinoma: Pathogenesis and Clinical Implications.
    Sung PS; Jang JW
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural Killer Cells in Liver Disease and Hepatocellular Carcinoma and the NK Cell-Based Immunotherapy.
    Liu P; Chen L; Zhang H
    J Immunol Res; 2018; 2018():1206737. PubMed ID: 30255103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAC1
    Shi X; Chen W; Yin Y; Cao H; Wang X; Jiang W; Li Q; Li X; Yu Y; Wang X
    Cancer Lett; 2024 Jun; 592():216909. PubMed ID: 38679407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression-free survival for patients with hepatocellular carcinoma.
    Cui J; Wang N; Zhao H; Jin H; Wang G; Niu C; Terunuma H; He H; Li W
    Int J Cancer; 2014 Jan; 134(2):342-51. PubMed ID: 23825037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer cells in hepatocellular carcinoma: current status and perspectives for future immunotherapeutic approaches.
    Yu M; Li Z
    Front Med; 2017 Dec; 11(4):509-521. PubMed ID: 28780700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients.
    Qian L; Wang N; Tian H; Jin H; Zhao H; Niu C; He H; Ge T; Han W; Hu J; Li D; Han F; Xu J; Ding X; Chen J; Li W; Cui J
    J Immunol Res; 2016; 2016():6837241. PubMed ID: 27069936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kbtbd2 inhibits the cytotoxic activity of immortalized NK cells through down-regulating mTOR signaling in a mouse hepatocellular carcinoma model.
    Dai K; Huang Y; Chen Z; Sun X; Yang L; Jiang Y
    Eur J Immunol; 2018 Apr; 48(4):683-695. PubMed ID: 29331106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin enhances NK cells immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signals.
    Shi L; Lin H; Li G; Sun Y; Shen J; Xu J; Lin C; Yeh S; Cai X; Chang C
    Cancer Lett; 2016 Apr; 373(1):45-56. PubMed ID: 26805759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural Killer Cell Expansion with Autologous Feeder Layer and Anti-CD3 Antibody for Immune Cell Therapy of Hepatocellular Carcinoma.
    Hosseinzadeh F; Ai J; Ebrahimi-Barough S; Seyhoun I; Hajifathali A; Muhammadnejad S; Hosseinzadeh F; Shadnoush M; Dabiri Oskouei F; Verdi J
    Asian Pac J Cancer Prev; 2019 Dec; 20(12):3797-3803. PubMed ID: 31870124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.